GLP-1 RA Drugs Show Promise, but Limitations Remain
A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...
GLP-1 RA Drugs Show Promise, but Limitations Remain
A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...
Progress
44% Bias Score
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
Progress
52% Bias Score
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes showed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues but increased the risk of 19 others, highlighting both benefits and risks of this increasingly popular medication.
GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study
A study of 1.4 million US veterans with type 2 diabetes showed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues but increased the risk of 19 others, highlighting both benefits and risks of this increasingly popular medication.
Progress
36% Bias Score
Chemotherapy Side Effects: Adele Roberts Reveals Fingertip Loss and Tongue Discoloration
Adele Roberts, a 45-year-old British TV and radio personality, recently disclosed the severe side effects of her chemotherapy treatment for bowel cancer, including the loss of her fingerprints and black spots on her tongue, despite being currently in remission after nine months of treatment.
Chemotherapy Side Effects: Adele Roberts Reveals Fingertip Loss and Tongue Discoloration
Adele Roberts, a 45-year-old British TV and radio personality, recently disclosed the severe side effects of her chemotherapy treatment for bowel cancer, including the loss of her fingerprints and black spots on her tongue, despite being currently in remission after nine months of treatment.
Progress
8% Bias Score
Study Links Long-Term Acetaminophen Use to Increased Health Risks in Older Adults
A U.K. study found that long-term acetaminophen use in older adults (1998-2018) was linked to increased risks of peptic ulcer bleeding, heart failure, and chronic kidney disease, prompting calls for careful consideration of its use as a first-line treatment for osteoarthritis.
Study Links Long-Term Acetaminophen Use to Increased Health Risks in Older Adults
A U.K. study found that long-term acetaminophen use in older adults (1998-2018) was linked to increased risks of peptic ulcer bleeding, heart failure, and chronic kidney disease, prompting calls for careful consideration of its use as a first-line treatment for osteoarthritis.
Progress
44% Bias Score
Lecanemab: EMA Approval and Limitations
EMA approves Lecanemab, a new Alzheimer's drug targeting amyloid plaques, but with limitations due to side effects and treatment complexity.
Lecanemab: EMA Approval and Limitations
EMA approves Lecanemab, a new Alzheimer's drug targeting amyloid plaques, but with limitations due to side effects and treatment complexity.
Progress
0% Bias Score
Finasteride's Dark Side: Online Access and Severe Side Effects
A 26-year-old British man, Kyle, suffered severe side effects, including suicidal thoughts and sexual dysfunction, after using finasteride obtained easily online last spring; this prompted the UK to mandate stronger warnings on the drug's packaging.
Finasteride's Dark Side: Online Access and Severe Side Effects
A 26-year-old British man, Kyle, suffered severe side effects, including suicidal thoughts and sexual dysfunction, after using finasteride obtained easily online last spring; this prompted the UK to mandate stronger warnings on the drug's packaging.
Progress
52% Bias Score
GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed
A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.
GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed
A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.
Progress
36% Bias Score
Weight-Loss Drugs Double Pancreatitis Risk: Major Study
A Washington University study of over 2 million diabetes patients found that weight-loss drugs like Ozempic doubled the risk of pancreatitis and increased risks of nausea/vomiting (30%), arthritis (11%), headaches (10%), and sleep disturbances (12%), despite also showing benefits in cardiovascular a...
Weight-Loss Drugs Double Pancreatitis Risk: Major Study
A Washington University study of over 2 million diabetes patients found that weight-loss drugs like Ozempic doubled the risk of pancreatitis and increased risks of nausea/vomiting (30%), arthritis (11%), headaches (10%), and sleep disturbances (12%), despite also showing benefits in cardiovascular a...
Progress
52% Bias Score
Fluoroquinolone Antibiotic Side Effects: Long-Term Disability and Underreporting
John Marshall, 51, from Kirkcaldy, Scotland, experienced debilitating joint pain and muscle spasms after taking fluoroquinolone antibiotics in 2017; seven years later, he still suffers chronic pain and muscle spasms, highlighting the rare but severe and potentially irreversible side effects of these...
Fluoroquinolone Antibiotic Side Effects: Long-Term Disability and Underreporting
John Marshall, 51, from Kirkcaldy, Scotland, experienced debilitating joint pain and muscle spasms after taking fluoroquinolone antibiotics in 2017; seven years later, he still suffers chronic pain and muscle spasms, highlighting the rare but severe and potentially irreversible side effects of these...
Progress
48% Bias Score
Weight-Loss Drugs: Successes and Side Effects
This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.
Weight-Loss Drugs: Successes and Side Effects
This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.
Progress
24% Bias Score